CORC

浏览/检索结果: 共16条,第1-10条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
Final analysis of phase 3 LATITUDE study in patients (pts) with newly diagnosed high-risk metastatic castration-naive prostate cancer (NDx-HR mCNPC) treated with abiraterone acetate plus prednisone (AA plus P) added to androgen deprivation therapy (ADT) 会议论文
作者:  Woo, H.;  Fizaz, K.;  Sulur, G.;  Tran, N.;  Fein, L.
收藏  |  浏览/下载:21/0  |  提交时间:2019/12/05
Safety and response to(177)Lu-EB-PSMA-617 in patients with metastatic castration-resistant prostate cancer 会议论文
JOURNAL OF NUCLEAR MEDICINE, 2019-05-01
作者:  Zang, Jie;  Liu, Qingxing;  Jacobson, Orit;  Niu, Gang;  Fan, Xinrong
收藏  |  浏览/下载:31/0  |  提交时间:2020/01/03
Safety and dosimetry of Lu-177-EB-PSMA617 in patients with metastatic castration-resistant prostate cancer 会议论文
JOURNAL OF NUCLEAR MEDICINE, 2018-05-01
作者:  Zang, Jie;  Wang, Hao;  Liu, Qingxing;  Jacobson, Orit;  Niu, Gang
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/03
Real-world use of docetaxel for metastatic castration-resistant prostate cancer in China: Results from a large observational study 会议论文
作者:  He, D.;  Sun, Z.;  Guo, J.;  Zhang, Z.;  Shan, Y.
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/05
Real-world use of docetaxel for metastatic castration-resistant prostate cancer in China: Results from a large observational study 会议论文
作者:  He, D.;  Sun, Z.;  Guo, J.;  Zhang, Z.;  Shan, Y.
收藏  |  浏览/下载:3/0  |  提交时间:2019/11/26
Efficacy, safety and pharmacokinetics (PK) of enzalutamide (ENZ) vs placebo (PL) in chemotherapy-naive patients (pts) with progressive metastatic castration-resistant prostate cancer (mCRPC): An Asian multinational study 会议论文
作者:  Ahn, H.;  Ye, D.;  Pu, Y-S.;  Han, W.;  Xie, L-P.
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05
Efficacy and safety of enzalutamide (ENZ) vs placebo (PL) in chemotherapy-naive patients (pts) with progressive metastatic castration-resistant prostate cancer (mCRPC) following androgen deprivation therapy (ADT): An Asian multinational study 会议论文
作者:  Ye, D.;  Ahn, H.;  Pu, Y-S.;  Weiqing, H.;  Xie, L-P.
收藏  |  浏览/下载:8/0  |  提交时间:2019/12/05
Phase 3 study of radium-223 dichloride (Ra-223) in Asian patients (pts) with castration-resistant prostate cancer (CRPC) and symptomatic bone metastases (mets) 会议论文
作者:  Sun, Y.;  Shi, H.;  Chen, C. -H.;  Lee, J. L.;  Kang, T. W.
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/19
Reactive stroma componentCOL6A1 is upregulated in castration-resistant prostate cancer and promotes tumor growth 会议论文
作者:  Zhu, Yiping;  Wan, Fangning;  Shen, Yijun;  Ye, Dingwei
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/19
Abiraterone acetate after docetaxel-based chemotherapy failure in Asian patients with metastatic castration-resistant prostate cancer 会议论文
作者:  Ye, Dingwei;  Zou, Qing;  Sun, Zhongquan;  Sun, Yinghao;  Li, Changling
收藏  |  浏览/下载:11/0  |  提交时间:2019/12/19


©版权所有 ©2017 CSpace - Powered by CSpace